Therapeutic effect of double‐filtration plasmapheresis combined with methylprednisolone to treat diffuse proliferative lupus nephritis

The efficacy of double‐filtration plasmapheresis (DFPP), combined with methylprednisolone, to treat diffuse proliferative lupus nephritis (LN) was studied.

[1]  Y. Takasaki,et al.  Long‐term Clinical Outcomes of Synchronized Therapy With Plasmapheresis and Intravenous Cyclophosphamide Pulse Therapy in the Treatment of Steroid‐resistant Lupus Nephritis , 2008, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[2]  L. Guillevin,et al.  Indications for plasma exchange in systemic lupus erythematosus in 2005 , 2005, Lupus.

[3]  Y. Levy,et al.  Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial. , 2004, Arthritis and rheumatism.

[4]  Lee Hebert,et al.  The classification of glomerulonephritis in systemic lupus erythematosus revisited. , 2004, Journal of the American Society of Nephrology : JASN.

[5]  T. Nakamura,et al.  Comparative effects of plasmapheresis and intravenous cyclophosphamide on urinary podocyte excretion in patients with proliferative Lupus nephritis. , 2002, Clinical nephrology.

[6]  G. Danieli,et al.  Synchronised therapy and high‐dose cyclophosphamide in proliferative lupus nephritis , 2002, Journal of clinical apheresis.

[7]  S. Abramson,et al.  Assessment of disease activity and impending flare in patients with systemic lupus erythematosus. Comparison of the use of complement split products and conventional measurements of complement. , 1992, Arthritis and rheumatism.

[8]  E. Lewis,et al.  A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group. , 1992, The New England journal of medicine.